A study published in the July issue of the journal SLEEP involved a cost-minimization analysis from the payer and provider perspectives comparing home sleep apnea testing (HSAT) and in-lab polysomnography (PSG) for the diagnosis and management of obstructive sleep apnea (OSA). Results show that a home-based management pathway for OSA is less costly to the payer; however, the home and laboratory-based pathways are similar in cost to the provider, which can result in a negative operating margin when performing HSAT according to standardized protocols designed to ensure patients receive high quality care.

Read the study in the journal SLEEP:  An Economic Evaluation of Home Versus Laboratory-Based Diagnosis of Obstructive Sleep Apnea